logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Mortality update of butadiene production workers.

    Article, Communication - En anglais

    Evaluation of Butadiene and Isopropene Health Risks. International Symposium. Blaine, Washington (USA), 1995/06/27.

    This is a further update of a cohort mortality study of 2795 male workers employed at least 6 months between 1942 and 1994 at a 1,3-butadiene facility.

    Earlier reports on this cohort found a statistically significant deficit for all causes of death and lower than expected mortality for most leading causes of death.

    Prior reports noted an excess of deaths from lymphosarcoma primarily in those employed less than 10 years, first employed before 1946, and employed in jobs with the potential for daily exposure to butadiene (BD).

    There was a nonsignificant elevation for leukemia in persons potentially exposed to BD on an intermittent basis.

    The purpose of this update was to examine the patterns of mortality with four additional years of follow-up.

    Persons who had become eligible since the cohort was last updated through 1990 were also added.

    A total of 1222 deaths were identified, and death certificates were obtained for all but 20 of the deaths (1.6%). The standardized mortality ratio (SMR) for all causes of death is 88 (95% confidence interval (Cl)=83-93), and for all cancer, the SMR is 92 (95% Cl=82-104).

    There were 42 deaths from lymphohematopoietic cancers (LHC) with 28.6 expected (SMR=147,95% Cl=106-198), 9 observed vs. 4.7 expected deaths for lymphosarcoma (SMR=191,95% CI=87-364), 13 observed vs. 11.5 expected deaths for leukemia (SMR=113,95% CI=60-193), and 15 observed vs. 9.9 expected deaths from cancer of other lymphatic tissue (SMR=152,95% CI=85-250). (...)

    Mots-clés Pascal : Butadiène, Exposition professionnelle, Industrie chimique, Mortalité, Carcinogène, Homme, Toxicité, Médecine travail, Tumeur maligne, Etude longitudinale, Epidémiologie

    Mots-clés Pascal anglais : Butadiene, Occupational exposure, Chemical industry, Mortality, Carcinogen, Human, Toxicity, Occupational medicine, Malignant tumor, Follow up study, Epidemiology

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 97-0027912

    Code Inist : 002B04E02. Création : 21/05/1997.